Discussion about this post

User's avatar
Michael Segal's avatar

As a Harvard faculty member who taught about AI in the 1980s (https://pubmed.ncbi.nlm.nih.gov/17747494/), I'm not surprised that others did the same as me and started companies. Indeed, the SBIR program encouraged that.

Thiel made some good points about barriers to innovation, but there has long been a tendency to assume that discoveries have slowed to a trickle and we are coasting off older breakthroughs. But part of the reason for this tendency is that it is hard to know if recent discoveries will become major changes. A good examples is the work of HMS professor Bruce Yankner that suggests that lithium deficiency is what enables Alzheimer disease to progress (https://hms.harvard.edu/news/could-lithium-explain-treat-alzheimers-disease). It is not yet clear whether this is correct, but if it is it will be a huge breakthrough.

Jonathan Gal's avatar

Very interesting to read Peter Theil's thoughts on these important topics.

I am a graduate of Harvard College in biology, after which I went to the NIH and worked on vaccine development. Strange as it may seem, I came out of vaccine development with some wild ideas about using microorganisms for various applications such as biofuels. The connection between the two topics may appear, especially to humanities majors, as a non sequitur, but it is probably better understood by microbiologists, molecular biologists and biochemists.

The molecular makeup of the microorganisms for which we were developing vaccine candidates includes several different kinds of high-energy and nutritious molecules, such as lipids, proteins, and carbohydrates, which can be extracted for use as raw material for energy production. Moreover, by focusing on photosynthetic microorganisms, one can harvest solar energy and convert it into chemical energy using the biosynthetic pathways that are embedded into the genomes of these organisms.

To make a long story short, I have been fascinated by the commercial and industrial potential of these concepts for many years. And, getting back to Peter Theil's interview, this is a scientific topic in which America lags far behind other countries. China, for example, is well ahead of us in this space, as are India and some European countries.

What makes China and India more interested in this topic is their high population relative to land area. As the Chinese economy grew over the past 3-4 decades since its free market reforms, one of the first "luxuries" that the rising Chinese masses sought after was more food ... especially protein rich foods. They were starving after Mao's disasterous and hard-edged socialist policies.

But, even today, they still cannot meet the protein needs of their vast population; hence their desire to purchase US farmland and to import US pork and soybeans for their protein content. The situation in India is similar. Recognizing their protein needs cannot be met with conventional farming, both China and India have invested funds into the study of photosynthetic microorganisms such as spirulina and chlorella as sources of edible protein.

As it turns out, these photosynthetic microorganisms are excellent protein sources, at least from a productivity standpoint. The flavor and gustatory attraction of these organisms fails to arouse much interest for obvious reasons (who wants to select "algae" from a menu?), but these issues can be overcome by using such proteins as food ingredients, not as foods by themselves. Moreover, gustatory trends can be changed with impactful marketing, and some cultures already enjoy eating spirulina as a food. In fact, certain tribes in Africa and South American have been doing it for centuries!

It is estimated by some that edible and nutritious spirulina protein can be produced at a rate of 200x more per acre than the average American beef cattle farm produces protein. And, this now leads me to my own startup.

I am developing a new kind of tubular photobioreactor (tPBR) that is now proven to increase Spirulina productivity by +41% over the previous generation of tPBR. That boosts the 200X protein advantage up to 282X compared to the average American beef cattle farm. And, I have some ideas about further technical improvements in these productivity measures.

Please visit our website for more information: https://chromaphorix.com

PS: With four kids and limited risk capital available, I am seeking investment in Chromaphorix. So, Peter, if you are reading this, please get in touch: jlglex99@chromaphorix.com.

Jonathan L. Gal

Harvard AB Biology Class of 1989 (graduated in June 1990 due to a year off)

5 more comments...

No posts

Ready for more?